Andrés Cerezo, L., Šumová, B., Prajzlerová, K., Veigl, D., Damgaard, D., Nielsen, C. H., . . . Šenolt, L. (2017). Calgizzarin (S100A11): A novel inflammatory mediator associated with disease activity of rheumatoid arthritis. Arthritis Res Ther.
Chicago Style CitationAndrés Cerezo, Lucie, Barbora Šumová, Klára Prajzlerová, David Veigl, Dres Damgaard, Claus Henrik Nielsen, Karel Pavelka, Jiří Vencovský, i Ladislav Šenolt. "Calgizzarin (S100A11): A Novel Inflammatory Mediator Associated With Disease Activity of Rheumatoid Arthritis." Arthritis Res Ther 2017.
Cita MLAAndrés Cerezo, Lucie, et al. "Calgizzarin (S100A11): A Novel Inflammatory Mediator Associated With Disease Activity of Rheumatoid Arthritis." Arthritis Res Ther 2017.
Atenció: Aquestes cites poden no estar 100% correctes.